4//SEC Filing
O'Neill Gilmore Neil 4
Accession 0001650664-25-000141
CIK 0001650664other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:20 PM ET
Size
5.0 KB
Accession
0001650664-25-000141
Insider Transaction Report
Form 4
O'Neill Gilmore Neil
DirectorCEO
Transactions
- Sale
Common Stock
2025-09-03$2.60/sh−5,592$14,517→ 274,690 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001742084
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:20 PM ET
- Size
- 5.0 KB